BMY Announces Opdivo+Yervoy Dosing Schedules Showed Acceptable Tolerability Profile
September 07, 2015 at 15:56 PM EDT
Bristol-Myers Squibb Company (NYSE: BMY) today announced updated results from the Opdivo (nivolumab)+Yervoy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.